Skip to main content
. 2020 Apr 20;40(4):453–458. doi: 10.12122/j.issn.1673-4254.2020.04.01

1.

1

Receiver-operating characteristic curve (ROC) comparing the neutrophils-lymphocytes ratio (NLR), C-reactive protein (CRP) and mean platelet volume (MPV) at 14 weeks for predicting LOR to infliximab in patients with Crohn's disease. The area under the ROC curve was 0.903 for NLR, 0.859 for CRP, and 0.688 for MPV.